-
psnet.ahrq.gov/node/836840/psn-pdf
April 22, 2021 - to patients and how to administer VTE prophylaxis. … Understand barriers to VTE prophylaxis at the institution. … clinical decision support tool for prophylaxis for venous
thromboembolism in trauma. … Venous
Thromboembolism Prophylaxis (eCQM). … clinical decision support tool for prophylaxis for
venous thromboembolism in trauma.
-
psnet.ahrq.gov/web-mm/hidden-heparins-hit-happens
March 27, 2024 - warfarin is introduced in a patient with HIT and typically begins within days of starting the oral anticoagulant … Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis. … Description
Indication
Dosing
Comment
Argatroban
Synthetic direct thrombin inhibitor
Prophylaxis … Related Resources
WebM&M Cases
Direct Oral Anticoagulants … See More About The Topic
Hospitals
Physicians
Risk Managers
Medicine
Anticoagulants
-
psnet.ahrq.gov/web-mm/comanagement-whos-charge
July 01, 2011 - Who is responsible for routine patient safety measures, such as deep venous thrombosis prophylaxis? … Because of the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.68_slideshow.ppt
July 01, 2004 - Referenced 4
PROWESS Exclusion
Drotrecogin alfa has anticoagulant properties, so patients at high … beta-blockers for coronary artery disease
ACE inhibitors for congestive heart failure
Pharmacologic prophylaxis
-
qualityindicators.ahrq.gov/Downloads/Resources/Case_Studies/Johns_Hopkins_Case_Study.pdf
August 01, 2019 - focuses on the identification of risk factors for VTE and ensuring that patients
receive the appropriate prophylaxis … The Collaborative identified service-specific champions, and
investigated strategies to improve VTE prophylaxis … The tool
requires patient risk stratification
and generates an algorithm for
administration of prophylaxis … Current improvement efforts
include compliance with ordering
and administration of appropriate prophylaxis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - 2
A variety of strategies to prevent VTE are available,
including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis,
within and between classes of VTE prophylaxis modalities,
and … duration of VTE prophylaxis in patients undergoing
these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE
prophylaxis versus no VTE prophylaxis did not provide
strong evidence … low SoE data on the
comparative effectiveness of aspirin or mechanical devices
with LMWH or other anticoagulants
-
effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - 2
A variety of strategies to prevent VTE are available,
including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis,
within and between classes of VTE prophylaxis modalities,
and … duration of VTE prophylaxis in patients undergoing
these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE
prophylaxis versus no VTE prophylaxis did not provide
strong evidence … low SoE data on the
comparative effectiveness of aspirin or mechanical devices
with LMWH or other anticoagulants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - 2
A variety of strategies to prevent VTE are available,
including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis,
within and between classes of VTE prophylaxis modalities,
and … duration of VTE prophylaxis in patients undergoing
these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE
prophylaxis versus no VTE prophylaxis did not provide
strong evidence … low SoE data on the
comparative effectiveness of aspirin or mechanical devices
with LMWH or other anticoagulants
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - 2
A variety of strategies to prevent VTE are available,
including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis,
within and between classes of VTE prophylaxis modalities,
and … duration of VTE prophylaxis in patients undergoing
these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE
prophylaxis versus no VTE prophylaxis did not provide
strong evidence … low SoE data on the
comparative effectiveness of aspirin or mechanical devices
with LMWH or other anticoagulants
-
effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-protocol/
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.14_slideshow.ppt
May 01, 2003 - Preventing Catheter-Related Thrombosis
Low molecular weight heparin
No clinical trials for prophylaxis
-
ce.effectivehealthcare.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
www.cpsi.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
www.cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
talkingquality.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
patientregistry.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
ahrqpubs.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
monahrq.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
healthcare411.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.
-
cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
December 01, 2017 - Bleeding concerns (e.g., anticoagulant use).
Blood availability.
Allergies. … Deep vein thrombosis prophylaxis.
Warmers.
Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis - 100% Yes.
Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes.
Access issues - 20% Yes.
Airway risk - 20% Yes.